Literature DB >> 35465304

T1 Mapping and Extracellular Volume in Cardiomyopathy Showing Left Ventricular Hypertrophy: Differentiation Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.

Lu Liang1, Xin Wang2, Yang Yu1, Yuan Zhang2, Jiamei Liu2, Mulei Chen2, Lin Zhang2, Tao Jiang1.   

Abstract

Background: The aim of this study was to evaluate the capability of different magnetic resonance imaging (MRI) parameters for distinguishing between hypertrophic cardiomyopathy (HCM) and hypertensive heart disease (HHD).
Methods: Thirty-eight patients with HCM, 35 patients with HHD, and 29 healthy controls subjects were enrolled in this study. All subjects underwent cardiac MRI to measure T1 values and extracellular volume (ECV), as well as the extent and patterns of late gadolinium enhancement (LGE). Myocardial segments were categorized as non-hypertrophic, mild-hypertrophic, moderate-hypertrophic, and severe-hypertrophic based on end-diastolic wall thickness (EDWT). The differences in native T1 values between all four groups were evaluated.
Results: Native T1 values were significantly higher in patients with HCM than in patients with HHD and in healthy controls (both P < 0.001). Moreover, significantly increased ECV was shown in patients with HCM than in patients with HHD and in healthy controls (both P = 0.001). Native T1 values in the basal slice and apex slice were significantly higher in patients with HCM than in patients with HHD (P < 0.01). In patients with HCM, the non-hypertrophic myocardial segments demonstrated significantly elevated T1 values compared with patients with HHD (both P < 0.001). Using a cut-off value of 28.8% for ECV, it could differentiate between HCM and HHD with 85% sensitivity, 62.07% specificity, and an area under the curve of 0.772.
Conclusion: In patients with HCM, T1 tissue remodeling occurs in the normal-appearing myocardial segments, but not in patients with HHD. Both native T1 values and ECV can support clinically relevant discrimination between HCM and HHD, although ECV had better diagnostic efficacy.
© 2022 Liang et al.

Entities:  

Keywords:  T1 mapping; extracellular volume; hypertrophic cardiomyopathy; magnetic resonance imaging

Year:  2022        PMID: 35465304      PMCID: PMC9030388          DOI: 10.2147/IJGM.S350673

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  27 in total

1.  Right Ventricular Function and T1-Mapping in Boys With Duchenne Muscular Dystrophy.

Authors:  Seraina A Dual; Nyasha G Maforo; Doff B McElhinney; Ashley Prosper; Holden H Wu; Shiraz Maskatia; Pierangelo Renella; Nancy Halnon; Daniel B Ennis
Journal:  J Magn Reson Imaging       Date:  2021-05-26       Impact factor: 4.813

Review 2.  The role of cardiovascular magnetic resonance imaging in heart failure.

Authors:  Theodoros D Karamitsos; Jane M Francis; Saul Myerson; Joseph B Selvanayagam; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2009-10-06       Impact factor: 24.094

3.  Hypertensive cardiomyopathy. Myocyte nuclei hyperplasia in the mammalian rat heart.

Authors:  P Anversa; T Palackal; E H Sonnenblick; G Olivetti; J M Capasso
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.

Authors:  Chunhua Wang; Jie Zheng; Jiayu Sun; Yuqing Wang; Rui Xia; Qian Yin; Wei Chen; Ziqian Xu; Jichun Liao; Bing Zhang; Fabao Gao
Journal:  J Cardiol       Date:  2015-05-14       Impact factor: 3.159

5.  T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.

Authors:  Rocio Hinojar; Niharika Varma; Nick Child; Benjamin Goodman; Andrew Jabbour; Chung-Yao Yu; Rolf Gebker; Adelina Doltra; Sebastian Kelle; Sitara Khan; Toby Rogers; Eduardo Arroyo Ucar; Ciara Cummins; Gerald Carr-White; Eike Nagel; Valentina O Puntmann
Journal:  Circ Cardiovasc Imaging       Date:  2015-12       Impact factor: 7.792

6.  Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride.

Authors:  S E Campbell; J S Janicki; B B Matsubara; K T Weber
Journal:  Am J Hypertens       Date:  1993-06       Impact factor: 2.689

7.  Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality.

Authors:  Timothy C Wong; Kayla Piehler; Christopher G Meier; Stephen M Testa; Amanda M Klock; Ali A Aneizi; Jonathan Shakesprere; Peter Kellman; Sanjeev G Shroff; David S Schwartzman; Suresh R Mulukutla; Marc A Simon; Erik B Schelbert
Journal:  Circulation       Date:  2012-07-31       Impact factor: 29.690

8.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Authors:  Valentina O Puntmann; Tobias Voigt; Zhong Chen; Manuel Mayr; Rashed Karim; Kawal Rhode; Ana Pastor; Gerald Carr-White; Reza Razavi; Tobias Schaeffter; Eike Nagel
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

9.  Think Small and Examine the Constituents of Left Ventricular Hypertrophy and Heart Failure: Cardiomyocytes Versus Fibroblasts, Collagen, and Capillaries in the Interstitium.

Authors:  Erik B Schelbert; Timothy C Wong; Mihai Gheorghiade
Journal:  J Am Heart Assoc       Date:  2015-09-15       Impact factor: 5.501

10.  In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  Wessel P Brouwer; Emma N Baars; Tjeerd Germans; Karin de Boer; Aernout M Beek; Jolanda van der Velden; Albert C van Rossum; Mark B M Hofman
Journal:  J Cardiovasc Magn Reson       Date:  2014-04-25       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.